Stockreport

Tempus and IFLI Announce Study to Advance Follicular Lymphoma Research [Yahoo! Finance]

Tempus AI, Inc. - Class A  (TEM) 
PDF CHICAGO, November 14, 2025 BUSINESS WIRE )--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announce [Read more]